Oral presentation at ASCO to highlight topline Phase 2 data of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

(Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating ...

Meanwhile, XRP faces mixed forecasts as analysts diverge on its next direction. Amidst this, BlockDAG (BDAG) is progressing swiftly. Its recent Keynote 3 announcement confirmed the Beta Testnet V1 is ...

Additionally, aerobic exercise, a popular form of physical activity, serves to enhance blood circulation and improve neuronal function. The article discusses various physical therapy ... that did not ...

This patent highlight describes a series of novel tricyclic system-based compounds as glycogen synthase kinase 3 (GSK3) inhibitors. The inhibitory potency of these compounds against GSK3α and GSK3β ...

IT之家4 月 3 日消息，Android 16的稳定版发布已近在咫尺，随着上个月 Beta 3 版本的推出，该系统已逐步迈入平台稳定阶段。然而，即便在这个阶段，仍有一些顽固的漏洞亟待修复。此前，谷歌通过 Android16 Beta 3.1 解决了部分问题，如今，Beta 3.2 版本又带来了一批新 ...

IT之家 4 月 3 日消息，Android 16 的稳定版发布已近在咫尺，随着上个月 Beta 3 版本的推出，该系统已逐步迈入平台稳定阶段。然而，即便在这个阶段 ...

Two weeks after the last patch, Google is rolling out Android 16 Beta 3.2 to Pixel devices. BP22.250221.015 with the March 2025 security patch is available for these supported devices: Pixel 6 ...

When Lea Wang ’26 first learned on Friday morning that she had been inducted into the Harvard College chapter of Phi Beta Kappa, she thought she was a victim of a scam. “You don’t really ...

The AI driven blockchain firm, WORLD3 has announced the launch of beta version of WORLD3 AI Agent Portal which is exclusively open to qualified early access members. This platform allows users to ...